Home › Funds › Champlain Investment Partners, LLC › TECH

Champlain Investment Partners, LLC position in TECH

BIO-TECHNE CORP · Health Care

Champlain Investment Partners, LLC reported holding 380,825 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$27.6M, representing 0.95% of its reported portfolio and ranking #29 among its reported holdings. Champlain Investment Partners, LLC has disclosed TECH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)380.82K sh
Reported value held$27.60M
Portfolio Weight0.95%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Champlain Investment Partners, LLC's TECH position evolved

Champlain Investment Partners, LLC first disclosed a stake in TECH in Q3 2023 at 2,692,309 shares (US$183.3M). The position peaked in Q4 2023 at 2,776,119 shares, worth US$214.2M. Across 13 filings, Champlain Investment Partners, LLC increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 380,825 shares valued at US$27.6M — a reduction of -53,906 shares quarter over quarter.. Notable position changes include a 36% trim in Q3 2025 (shares rose 6% over the following quarter), a 70% trim in Q2 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.69M $183.27M New
Q4 2023 2.78M $214.21M Add
Q1 2024 2.74M $193.20M Reduce
Q2 2024 2.68M $191.83M Reduce
Q3 2024 2.61M $208.33M Reduce
Q4 2024 2.42M $174.29M Reduce
Q1 2025 2.45M $143.55M Add
Q2 2025 2.67M $137.15M Add
Q3 2025 1.70M $94.70M Reduce
Q4 2025 1.40M $82.56M Reduce
Q1 2026 1.45M $75.99M Add
Q2 2026 434.73K $30.71M Reduce
Q3 2026 380.82K $27.60M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 27 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has Champlain Investment Partners, LLC held TECH?

Champlain Investment Partners, LLC has disclosed TECH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Champlain Investment Partners, LLC's current position in TECH?

As of Q3 2026, Champlain Investment Partners, LLC holds 380.82K shares of TECH (BIO-TECHNE CORP), valued at $27.60M, representing 0.95% of its reported portfolio and ranking #29.

Has Champlain Investment Partners, LLC been buying or selling TECH?

In the latest 13F filing (Q3 2026), Champlain Investment Partners, LLC reduced its position in TECH. The position peaked in Q4 2023 at 2.78M shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.